Estimated impact of fezolinetant versus placebo on work productivity and indirect costs among women experiencing vasomotor symptoms associated with menopause
- DOI
- 10.1097/gme.0000000000002755
- Published
- 2026-03-31
- Container
- Menopause
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/gme.0000000000002755,
title = {Estimated impact of fezolinetant versus placebo on work productivity and indirect costs among women experiencing vasomotor symptoms associated with menopause},
author = {Antonia Morga and Ting-An Tai and Ritika Kapoor and Wei Song and Qi Hua and Yechu Hua and Hongbo Yang and Mayank Ajmera},
year = {2026},
journal = {Menopause},
doi = {10.1097/gme.0000000000002755},
url = {https://doi.org/10.1097/gme.0000000000002755}
}RIS
TY - JOUR TI - Estimated impact of fezolinetant versus placebo on work productivity and indirect costs among women experiencing vasomotor symptoms associated with menopause AU - Antonia Morga AU - Ting-An Tai AU - Ritika Kapoor AU - Wei Song AU - Qi Hua AU - Yechu Hua AU - Hongbo Yang AU - Mayank Ajmera PY - 2026 JO - Menopause DO - 10.1097/gme.0000000000002755 UR - https://doi.org/10.1097/gme.0000000000002755 ER -
APA
Morga, A., Tai, T., Kapoor, R., Song, W., Hua, Q., Hua, Y., Yang, H., & Ajmera, M. (2026). Estimated impact of fezolinetant versus placebo on work productivity and indirect costs among women experiencing vasomotor symptoms associated with menopause. Menopause. https://doi.org/10.1097/gme.0000000000002755
Source records
- crossref · retrieved 2026-09-26T12:20:16.744Z